Edaravone
CAS 89-25-8 12 FDA-DMF suppliersSmall Molecule
Overview
Edaravone is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL290916).
Patent & exclusivity (US)
Per the FDA Orange Book (6 approved US products), the latest listed US patent on Edaravone expires 12 Nov 2041 and exclusivity 11 May 2029. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 5-methyl-2-phenyl-4H-pyrazol-3-one
- Canonical SMILES
- CC1=NN(C(=O)C1)C2=CC=CC=C2
- InChIKey
- QELUYTUMUWHWMC-UHFFFAOYSA-N
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.